Hospital
Evangelical Community Hospital
Evangelical Community Hospital was paid $4.42M by Medicaid between Jan 2018 and Dec 2024, across 195 billing codes. Its largest line is 99284, emergency room visit (serious) — 23% of everything it billed.
33Billing provider infoEVANGELICAL COMMUNITY HOSPITAL
LEWISBURG, PA 17837
LEWISBURG, PA 17837
33aNPI1124076039assigned 05/04/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.42M
24GClaims151,364
24DCodes billed195
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#67 of 154
Median peer was paid$2.82M
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 184 | $51K | |
| 2019 | 832 | $14K | |
| 2020 | 24,138 | $628K | |
| 2021 | 77,721 | $2.27M | |
| 2022 | 23,147 | $671K | |
| 2023 | 14,942 | $379K | |
| 2024incomplete | 10,400 | $408K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 13,390 | 12,911 | $998K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 13% | 6,444 | 6,242 | $592K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.8% | 5,788 | 5,646 | $258K |
| 87631 | 4.5% | 1,333 | 1,315 | $200K | |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 3.8% | 5,499 | 1,854 | $169K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.6% | 927 | 909 | $161K |
| G0378 | Hospital observation service, per hour | 3.5% | 177 | 173 | $153K |
| 80053 | Comprehensive metabolic panel | 3.1% | 12,657 | 11,768 | $136K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2.7% | 636 | 613 | $119K |
| X0621 | 2.0% | 372 | 233 | $87K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 14,753 | 13,328 | $80K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.7% | 2,550 | 2,457 | $76K |
183 more codes
| 99285 | Emergency room visit (most serious) | 1.6% | 1,566 | $70K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.4% | 1,523 | $64K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.4% | 306 | $62K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.3% | 1,764 | $55K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.1% | 4,017 | $50K |
| 450 | Pov group 1 hd 301-450 lbs | 1.1% | 65 | $48K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.0% | 5,000 | $46K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 855 | $44K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 502 | $44K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,311 | $41K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,734 | $38K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 545 | $33K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 398 | $31K |
| 93976 | <1% | 307 | $27K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 775 | $26K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 278 | $23K |
| 81001 | <1% | 6,938 | $21K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 123 | $20K |
| 93971 | <1% | 317 | $20K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,571 | $19K |
| 84484 | <1% | 2,192 | $19K | |
| 87150 | <1% | 276 | $19K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,347 | $18K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 446 | $17K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 257 | $17K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 645 | $17K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 645 | $17K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,279 | $17K |
| 80061 | Lipid panel | <1% | 1,271 | $16K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 454 | $16K |
| 84703 | <1% | 1,360 | $15K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 394 | $14K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 402 | $13K |
| 97162 | <1% | 321 | $13K | |
| 76830 | Ultrasound, transvaginal | <1% | 252 | $12K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 200 | $12K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,704 | $12K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 499 | $12K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 45 | $11K |
| 76536 | <1% | 241 | $11K | |
| 97161 | <1% | 270 | $11K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 695 | $9K |
| 84702 | <1% | 510 | $9K | |
| 76642 | <1% | 235 | $9K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 256 | $9K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 191 | $9K |
| 76770 | <1% | 190 | $8K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 150 | $8K |
| 87040 | <1% | 612 | $7K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 161 | $7K |
| 80050 | General health panel | <1% | 146 | $6K |
| 86803 | <1% | 291 | $6K | |
| 71045 | Radiologic examination, chest; single view | <1% | 878 | $6K |
| 85379 | <1% | 584 | $6K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 967 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 609 | $6K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,097 | $6K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 12 | $6K |
| 83690 | <1% | 1,149 | $5K | |
| 83605 | <1% | 807 | $5K | |
| 87088 | <1% | 635 | $5K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 193 | $5K |
| 73610 | <1% | 268 | $5K | |
| 86787 | <1% | 237 | $5K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 77 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,733 | $4K |
| 78227 | <1% | 14 | $4K | |
| 86850 | <1% | 538 | $4K | |
| 87186 | <1% | 555 | $4K | |
| 76801 | <1% | 91 | $4K | |
| 73564 | <1% | 190 | $4K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 198 | $4K |
| 86762 | <1% | 153 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 68 | $3K |
| 72141 | <1% | 13 | $3K | |
| 83735 | <1% | 559 | $3K | |
| 73221 | <1% | 14 | $3K | |
| 82728 | <1% | 277 | $3K | |
| 83880 | <1% | 172 | $3K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 196 | $3K |
| 320 | <1% | 18 | $3K | |
| 84439 | <1% | 346 | $3K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 303 | $3K |
| 70486 | <1% | 40 | $2K | |
| 73030 | <1% | 196 | $2K | |
| 87071 | <1% | 417 | $2K | |
| 70496 | <1% | 12 | $2K | |
| 73630 | <1% | 211 | $2K | |
| 82607 | <1% | 219 | $2K | |
| 74018 | <1% | 191 | $2K | |
| 96367 | <1% | 120 | $2K | |
| 86900 | <1% | 575 | $2K | |
| 86901 | <1% | 570 | $2K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 335 | $2K |
| 97597 | <1% | 145 | $2K | |
| 82950 | <1% | 269 | $2K | |
| 85610 | <1% | 794 | $2K | |
| A9270 | Non-covered item or service | <1% | 195 | $2K |
| 80076 | <1% | 191 | $2K | |
| 82570 | <1% | 254 | $2K | |
| 86038 | <1% | 109 | $2K | |
| 73130 | <1% | 158 | $2K | |
| 87340 | <1% | 120 | $2K | |
| 72100 | <1% | 89 | $2K | |
| 85730 | <1% | 311 | $2K | |
| 93017 | <1% | 67 | $2K | |
| 83540 | <1% | 191 | $2K | |
| 96376 | <1% | 55 | $2K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 27 | $2K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 90 | $2K |
| 81025 | <1% | 227 | $1K | |
| 87077 | <1% | 142 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 25 | $1K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 43 | $1K |
| 85652 | <1% | 409 | $1K | |
| 86140 | <1% | 429 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 16 | $998.62 |
| 81003 | <1% | 334 | $988.47 | |
| 86592 | <1% | 225 | $978.23 | |
| 12001 | <1% | 14 | $890.64 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,789 | $801.59 |
| 300 | Patient transfer system <300 | <1% | 101 | $800.61 |
| 82948 | <1% | 309 | $779.10 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 106 | $767.21 |
| 77065 | Tomosynthesis, mammo | <1% | 12 | $758.21 |
| 73110 | <1% | 64 | $746.71 | |
| 86318 | <1% | 32 | $718.55 | |
| 93970 | <1% | 13 | $701.01 | |
| 82010 | <1% | 173 | $697.42 | |
| 84145 | <1% | 64 | $632.67 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 12 | $614.95 |
| 93925 | <1% | 14 | $597.88 | |
| 90715 | <1% | 50 | $577.53 | |
| 82043 | <1% | 73 | $570.43 | |
| 87081 | <1% | 94 | $557.88 | |
| 84100 | <1% | 130 | $542.27 | |
| 87641 | <1% | 15 | $524.64 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 378 | $513.74 |
| 73502 | <1% | 28 | $476.61 | |
| 82550 | <1% | 73 | $458.93 | |
| 73562 | <1% | 30 | $448.62 | |
| 84466 | <1% | 25 | $415.81 | |
| 82803 | <1% | 17 | $382.40 | |
| 86618 | <1% | 13 | $369.62 | |
| 86431 | <1% | 42 | $364.60 | |
| 82947 | <1% | 78 | $354.15 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 13 | $333.08 |
| 86922 | <1% | 12 | $330.40 | |
| 85018 | <1% | 121 | $295.67 | |
| 84146 | <1% | 12 | $273.63 | |
| 71250 | <1% | 12 | $264.95 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,657 | $236.67 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 23 | $236.54 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 746 | $225.93 |
| 87808 | <1% | 12 | $169.91 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 259 | $164.53 |
| 73080 | <1% | 13 | $154.96 | |
| 83655 | <1% | 12 | $146.00 | |
| 84550 | <1% | 29 | $144.85 | |
| 83615 | <1% | 31 | $126.35 | |
| 84156 | <1% | 25 | $117.97 | |
| 85027 | <1% | 15 | $113.56 | |
| 87070 | <1% | 12 | $104.16 | |
| 82375 | <1% | 18 | $80.11 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 457 | $63.59 |
| 83050 | <1% | 17 | $42.89 | |
| 86905 | <1% | 13 | $36.26 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 213 | $30.30 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 121 | $25.52 |
| J2704 | Injection, propofol, 10 mg | <1% | 40 | $20.80 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 56 | $11.86 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 20 | $11.28 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 125 | $11.04 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 196 | $10.04 |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | <1% | 25 | $9.81 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 53 | $4.45 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 0% | 203 | $0.00 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 102 | $0.00 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 0% | 457 | $0.00 |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | 0% | 148 | $0.00 |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 0% | 17 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 17 | $0.00 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 0% | 203 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAUCKER, KENDRA (SENIOR VICE PRESIDENT/PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Evangelical Medical Services Organization | Lewisburg, PA | $1.46M |
| Evangelical Medical Services Organization | Lewisburg, PA | $1.27M |
| Evangelical Medical Services Organization | Lewisburg, PA | $1.09M |
| Evangelical Medical Services Organization | Lewisburg, PA | $816K |
| Evangelical Regional Mobile Medical Services, LLC | Lewisburg, PA | $709K |
| Evangelical Medical Services Organization | Lewisburg, PA | $68K |
| Evangelical Community Hospital | Lewisburg, PA | $39K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.